- Report
- June 2024
- 238 Pages
Global
From €7208EUR$7,950USD£6,161GBP
- Report
- February 2022
- 269 Pages
Global
From €8614EUR$9,500USD£7,362GBP
- Report
- October 2024
- 200 Pages
Global
From €3400EUR$3,750USD£2,906GBP
- Report
- July 2025
- 200 Pages
Philippines
From €2529EUR$2,789USD£2,161GBP
- Report
- June 2025
- 150 Pages
Global
From €2447EUR$2,699USD£2,092GBP
- Report
- September 2024
- 250 Pages
Global
From €4487EUR$4,949USD£3,835GBP
- Report
- August 2024
- 150 Pages
Global
From €2529EUR$2,789USD£2,161GBP
- Report
- May 2024
- 160 Pages
Global
From €4505EUR$4,969USD£3,851GBP
- Report
- November 2023
- 200 Pages
Global
From €3263EUR$3,599USD£2,789GBP
- Report
- June 2025
- 200 Pages
Global
From €2529EUR$2,789USD£2,161GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2529EUR$2,789USD£2,161GBP
- Report
- June 2025
- 400 Pages
Global
From €4487EUR$4,949USD£3,835GBP
- Report
- February 2026
- 137 Pages
Australia
From €3626EUR$3,999USD£3,099GBP
- Report
- February 2024
- 110 Pages
Global
From €4307EUR$4,750USD£3,681GBP
- Report
- May 2024
- 137 Pages
Global
From €2719EUR$2,999USD£2,324GBP
€3626EUR$3,999USD£3,099GBP
- Report
- May 2024
- 136 Pages
Global
From €2719EUR$2,999USD£2,324GBP
€3626EUR$3,999USD£3,099GBP
- Report
- May 2024
- 135 Pages
Global
From €2719EUR$2,999USD£2,324GBP
€3626EUR$3,999USD£3,099GBP
- Report
- May 2024
- 138 Pages
Global
From €2719EUR$2,999USD£2,324GBP
€3626EUR$3,999USD£3,099GBP
- Report
- May 2024
- 128 Pages
Global
From €2719EUR$2,999USD£2,324GBP
€3626EUR$3,999USD£3,099GBP
- Report
- April 2024
- 115 Pages
Global
From €4080EUR$4,500USD£3,487GBP

The Dermatologicals market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin diseases, including acne, psoriasis, eczema, and skin cancer. Dermatologicals are typically administered topically, although some may be taken orally. The market is highly competitive, with a wide range of products available from both generic and branded manufacturers.
The Dermatologicals market is driven by the increasing prevalence of skin diseases, as well as the development of new treatments and technologies. Additionally, the increasing demand for cosmetic treatments has also contributed to the growth of the market.
Some of the major companies in the Dermatologicals market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. Other notable players include Allergan, Galderma, and Sun Pharmaceuticals. Show Less Read more